Actos May Lower Heart Disease Risk In Diabetics With Kidney Disease
December 15, 2007 by MedHeadlines
Filed under Diabetes, Drugs, Heart Disease, Renal Disease
Med Headlines - A study conducted in Cologne, Germany, concluded that pioglitazone (Actos) may lower the risk of serious cardiovascular events for diabetic patients who have kidney disease. The study, which is featured in the January issue of the Journal of the American Society of Nephrology, was conducted by Dr. Chistian A. Schneider of the University of Cologne. Read more





